Glassware combines safety and performance
KIMAX GL 45 storage/media bottles are made with Type 1 Class A borosilicate glass
The bottles are available with linerless, autoclavable (up to 140°C) polypropylene GL 45 caps with an internal seal. For easy identification, they can be specified with blue, white or orange caps.
Other caps available include a red PBT (polybutyleneterephthalate) cap with PTFE/silicone liner (up to 180°C) offering resistance to solvents and acids.
A blue vented cap (up to 140°C) is also available for equalising pressure during autoclaving. An extra wide neck opening facilitates access, and replaceable polypropylene pour rings minimise drips while pouring.
KIMAX storage/media bottles feature permanent, white enamel graduations and marking spots. For enhanced safety, the bottles may be treated with KimCote, an ultra-clear coating that is applied to the exterior of laboratory glassware to resist breakage and contain leaking.
For light-sensitive compounds, Kimble Chase offers RAY-SORB treated glassware.
Kimble Chase Life Science and Research Products, based in Vineland, New Jersey, was formed in July 2007 through a joint venture between specific operations of Thermo Fisher Scientific and Gerresheimer Glass. The company designs and manufactures reusable, disposable and specialist glassware for laboratories across a range of industries, including pharmaceuticals and life sciences.
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model